Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

48.29
Delayed Data
As of Sep 01
 -1.30 / -2.62%
Today’s Change
44.80
Today|||52-Week Range
76.69
-14.33%
Year-to-Date

Today’s Trading

Previous close49.59
Today’s open48.56
Day’s range47.90 - 49.66
Volume6,601,930
Average volume (3 months)7,196,032
Market cap$24.4B
Dividend yield--
Data as of 3:59pm ET, 09/01/2015

Growth & Valuation

Earnings growth (last year)+48.10%
Earnings growth (this year)+18.14%
Earnings growth (next 5 years)+10.65%
Revenue growth (last year)+12.42%
P/E ratio20.8
Price/Sales2.89
Price/Book5.71

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc-0.89-1.98%
PRGOPerrigo Company PLC-3.51-1.92%
INCYIncyte Corp-1.07-0.92%
BMRNBiomarin Pharmaceuti...-4.61-3.57%
Data as of 4:02pm ET, 09/01/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)$1.37
Annual revenue (last year)$7.8B
Annual profit (last year)$929.4M
Net profit margin11.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Potters Bar, Hertfordshire

Forecasts

Partner Offers